Period Ending: | 2019 30/09 | 2020 30/09 | 2021 30/09 | 2022 30/09 | 2023 30/09 | 2024 30/09 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenues | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 40,043 | |||||||||
Total Revenues Growth | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | +6.35% | |||||||||
Cost Of Revenues | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 8,230 | |||||||||
Gross Profit | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 31,813 | |||||||||
Gross Profit Growth | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | +4.95% | |||||||||
Gross Profit Margin % | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 79.45% | |||||||||
Other Operating Expenses, Total | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 27,635 | |||||||||
| |||||||||||||||
Operating Income | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 4,178 | |||||||||
Operating Income Growth | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | +11.26% | |||||||||
EBIT Margin % | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 10.43% | |||||||||
Net Interest Expenses | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 8 | |||||||||
Net Interest Expenses Growth | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | +500% | |||||||||
Interest Expense, Total | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -1 | |||||||||
Interest And Investment Income | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 9 | |||||||||
Other Non Operating Expenses, Total | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -63 | |||||||||
EBT, Excl. Unusual Items | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 4,123 | |||||||||
Gain (Loss) On Sale Of Assets | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -7 | |||||||||
Other Unusual Items, Total | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 6 | |||||||||
EBT, Incl. Unusual Items | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 4,109 | |||||||||
EBT, Incl. Unusual Items Growth | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | +16.44% | |||||||||
EBT, Incl. Unusual Items Margin | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 10.26% | |||||||||
Income Tax Expense | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 1,314 | |||||||||
Net Income to Company | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 2,795 | |||||||||
Minority Interest | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | - | |||||||||
Net Income | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 2,795 | |||||||||
Net Income Growth | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | +16.75% | |||||||||
Net Income Margin % | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 6.98% | |||||||||
Preferred Dividend and Other Adjustments | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | - | |||||||||
Net Income to Common Excl. Extra Items | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 2,795 | |||||||||
Basic EPS - Continuing Operations | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 129.67 | |||||||||
Basic EPS - Continuing Operations Growth | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | +16.45% | |||||||||
Diluted EPS - Continuing Operations | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 129.29 | |||||||||
Diluted EPS - Continuing Operations Growth | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | +16.68% | |||||||||
Basic Weighted Average Shares Outstanding | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 21.56 | |||||||||
Diluted Weighted Average Shares Outstanding | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 21.62 | |||||||||
Dividend Per Share | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 35 | |||||||||
Dividend Per Share Growth | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | +6.06% | |||||||||
EBITDA | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 4,568 | |||||||||
EBITDA Growth | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | +9.07% | |||||||||
EBITDA Margin % | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 11.41% | |||||||||
EBIT | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 4,178 | |||||||||